Caligan Partners LP
Source: SEC Form 13F · as of Mar 2026Caligan Partners LP holds 14 biotech & pharma companies tracked by BioSniper, totaling $1.12B in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$1.12B
BioSniper AIPage evidence connected
Prepared research question
What matters most for Liquidia Corp (LQDA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| LQDALiquidia Corp | 8,118,892 | $306.4M |
| ABVXAbivax SA | 1,461,924 | $162.8M |
| RVMDREVOLUTION MEDICINES, INC. | 1,652,808 | $160.7M |
| PCVXVaxcyte, Inc. | 2,060,719 | $119.7M |
| EXELEXELIXIS, INC. | 1,553,262 | $66.6M |
| TNGXTango Therapeutics, Inc. | 2,408,798 | $50.4M |
| SYRESpyre Therapeutics, Inc. | 878,127 | $44.3M |
| ADMAADMA BIOLOGICS, INC. | 4,756,511 | $42.9M |
| LBRXLB PHARMACEUTICALS INC | 1,438,070 | $34.6M |
| SABSSAB BIOTHERAPEUTICS, INC. | 7,967,207 | $30.5M |
| IRDOpus Genetics, Inc. | 6,075,028 | $27.6M |
| IVAInventiva S.A. | 4,974,906 | $27.6M |
| AVTXAvalo Therapeutics, Inc. | 1,635,023 | $24.4M |
| MAZEMaze Therapeutics, Inc. | 614,962 | $18.4M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.